Publish Date : 2/1/2006 10:33:00 PM Source : Health News Onlypunjab.com. The European Commission has given approval for GlaxoSmithKline Plc's Hycamtin drug to be used as a treatment for small cell lung cancer, Europe's biggest drug maker said today. The medicine, which is given by infusion, is already used for ovarian cancer and its extension to lung cancer had been expected, following a positive opinion from an expert panel in November.
